Dr. A. B.
General Management - Deputy Director

Dr. A. B.
General Management - Deputy Director
Ph.D. in Advanced Neuroscience, Valcroix-de-Jouvence Institute
Molecular Neurology
15+ years of experience
21 patents
99.7% success rate
Creator of the IM-19 protocol for Immune Modulation. Research Director in quantum neuroscience and psychiatric regenerative medicine, focused on therapeutic innovation.
Areas of expertise
Dr. A. specializes in several cutting-edge areas of molecular neurology.
21
Scientific patents
30
International publications
856
Patients treated
99.7%
Success rate
Recent publications
Neuronal repair through targeted molecular modulation
LX-42 Protocol: Results from a phase III clinical trial
Innovations in treating degenerative neurological lesions
LX-42 Protocol: Results from a phase III clinical trial
Neuronal repair through targeted molecular modulation
Professional background
Dr. A. has built an exceptional career in the field of molecular neurology.
- 2010: Doctoral Degree - Ph.D. in Advanced Neuroscience, Valcroix-de-Jouvence Institute
- 2012 - 2015: Research Associate - Lyon Center for Excellence in Molecular Medicine
- 2015 - 2018: Research Project Leader - Strasbourg Biomedical Research Center
- 2018 - 2023: Deputy Director of General Management - Deputy Director - International Clinic of Bern
- 2023 - Present: General Management - Deputy Director - ClairEssence Clinic